国产午夜福利精品_網友分享114一级毛片免费观看心得_天堂在线最新版www中文天堂_亚洲欧洲无码一区_最近2018中文字幕免费看_污的网站在线观看_无码一级午夜福利_成人在线免费自拍_奇米777在线视频_丰满人妻中文字幕乱码
Home
About Us
Company Profile
Enterprise Honor
CEO Message
Core Team
Company Culture
Development History
Technologies
Sterile Preparations
Non-sterile Preparation
Service
CMC Study
Manufacture
Preclinical Study
Clinical Study
Drugs Registration
Products
Products
Pipeline
Quality
Contact Us
Contact Details
Online Message
EN
EN
中文
About Us
About Us
Company Profile
Enterprise Honor
CEO Message
Core Team
Company Culture
Development History
YEAR
2023
◆ Bostal completed the series B1 financing.
◆ Gastric floating metformin hydrochloride sustained-release tablet was approved for market launch.
◆ Bostal was selected as one of SRDI small and medium-sized enterprises in Guangdong Province.
◆ Bostal's key research project of Guangdong Province, "Core Key Technology of Industrialization of New Gastric Retention Drug Delivery System", passed the acceptance test successfully.
YEAR
2022
◆ The new analytical laboratory located in the industrial park was completed and put into use.
◆ The complex injection workshop and the ointment workshop were completed and put into use.
◆ Bostal passed the EU QP audit, representing that the quality system met the EU GMP standard.
◆ Bostal was certified as a high-tech enterprise again.
YEAR
2021
◆ Bostal's first sterile nanocrystal manufacturing workshop was completed and put into use.
◆ Bostal completed the series B1 financing.
◆ Bostal's research platform was awarded with the title of "Guangdong Provincial Engineering Center for New Drug Delivery System".
◆ Bostal's high-end public service platform for R&D and industrialization of pharmaceutical formulation technologies passed the acceptance inspection of emerging industry projects successfully.
YEAR
2020
◆ The solid dosage workshop of Bostal manufacturing base was put into operation.
◆ Bostal passed the GMP compliance inspection by NMPA, and became an GMP-compliant enterprise in both China and the United States.
◆ Entecavir Tablet, the first self-developed product of Bostal, was approved for market launch.
◆ Bostal was awarded with the titles of "Guangzhou Demonstration Institution for Science and Technology Service" and "Guangzhou Demonstration Enterprise for Service and Trade".
YEAR
2019
◆ The site at Enterprise Accelerator passed the US FDA inspection again.
◆ Bostal was certified as a high-tech enterprise again.
◆ Bostal was included in the List of 2019 Guangzhou Future Unicorn Innovative Company.
◆ Bostal was selected as one of the Gazelle Enterprises in Huangpu District.
YEAR
2018
◆ Bostal passed the US FDA inspection without any defect identified, and became the first prescription drug manufacturer passing the US FDA inspection in Guangzhou.
◆ Guangzhou BioCR Co., Ltd, a wholly-owned subsidiary of Bostal, was officially registered and established.
YEAR
2017
◆ Groundbreaking for industrialization base.
◆ Bostal completed the series A financing.
◆ The core team was selected as one of the Guangzhou Entrepreneurship Teams.
◆ Ron Liu was selected as a candidate of the national major projects for talent development.
YEAR
2016
◆ The second-phase expansion project of the R&D center for sustained-release and controlled-release durgs was completed.
◆ Bostal was certified as a high-tech enterprise for the first time.
◆ Bostal was awarded with the title of “Guangzhou Enterprise R&D Institution”.
◆ The core team of Bostal was selected as one of the Guangdong Provincial Innovation and Entrepreneurship Teams.
◆ Ron Liu was selected as the one of the leading talents in the Guangzhou Development District.
YEAR
2015
◆ The construction of R&D center and oral solid dosage manufacturing workshop was completed and put into use at the Enterprise Accelerator.
YEAR
2014
◆ In October 2014, Bostal moved in the Technology Enterprise Accelerator at Guangzhou Development District, and built a R&D center for sustained-release and controlled-release drugs, and a manufacturing workshop of oral solid drugs.
YEAR
2013
◆ In July 2013, Bostal was established in the National Enterprise Incubator at Guangzhou Science City.
Menu
×
Home
About Us
Company Profile
Enterprise Honor
CEO Message
Core Team
Company Culture
Development History
Technologies
Sterile Preparations
Non-sterile Preparation
Service
CMC Study
Manufacture
Preclinical Study
Clinical Study
Drugs Registration
Products
Products
Pipeline
Quality
Contact Us
Contact Details
Online Message